ABSTRACT: Background. Current prognostic criteria are insufficient in predicting outcomes in head and neck cancer, necessitating new, readily available biomarkers. Methods. Pretreatment neutrophil and lymphocyte counts and their ratio (NLR) were retrospectively investigated for correlation with overall survival while controlling for demographic and clinical confounders. Results. Patients in the highest tertile of neutrophil counts and those in the lowest tertile of lymphocytes experienced shorter survival than the rest of the population. Patients in the highest tertile of the NLR were at a higher risk compared with those in the lowest tertile after multivariate analysis (hazard ratio [HR] 5 2.39; p 5 .0001). Additionally, NLR was lower in patients with human papillomavirus (HPV)-positive tumors compared to HPV-negative tumors and predicted survival in both tumor types. Conclusion. Neutrophil and lymphocyte counts are strong biomarkers with opposing prognostic significance and the NLR is a robust predictor of overall survival in oral, pharyngeal, and laryngeal squamous cell carcinomas.
INTRODUCTION
Head and neck cancer accounts for more than half a million new cases annually, ranking it as the fifth most common cancer worldwide, 1 and cancers of squamous mucosa constitute the vast majority of cases. Major risk factors for head and neck squamous cell carcinoma (HNSCC) include smoking, alcohol consumption, 2 and infection with oncogenic strains of human papillomavirus (HPV). 3 Disease stage is the single most predictive prognostic factor, including primary tumor size, lymph node involvement, and distant metastasis, in addition to extracapsular and perineural invasion. 4, 5 However, these parameters are not sufficient for identifying patients at highest risk for recurrence, as there is significant heterogeneity in outcome within single stage groups. Additional prognostic information based on readily available markers, such as hematological parameters, would be of obvious clinical utility.
The relationship between cancer and the immune system has been increasingly recognized over the past three decades. 6 Although immune-surveillance is a strong line of defense by which transformed cells are cleared by the immune system, chronic inflammation is an established risk factor for developing several types of cancer, including colon cancer, hepatocellular carcinoma, and gastric cancer. 6 In addition, the tumor microenvironment is infiltrated by a heterogeneous population of immune cells, each playing a different role in the cross-talk between cancer cells and the host, either favoring or suppressing tumor progression. For example, a subset of myeloid cells, which is expanded in patients with cancer are myeloid-derived suppressor cells (MDSCs). These are immature myeloid cells of granulocytic or monocytic lineages that are elevated in cancer. 7 MDSCs are capable of attenuating antitumor T cell activity and promoting tumor angiogenesis. 7 In fact, a higher number of circulating MDSCs is a poor prognostic indicator in esophageal, gastric, and pancreatic cancers. 8 On the other hand, higher lymphocyte infiltration in the tumor (tumor-infiltrating lymphocytes) correlates with better prognosis in HNSCC. 9 In turn, cancer cells modify the behavior of neutrophils by inducing the release of cytokines and metalloproteinases, increasing their chemotactic potential and inhibiting apoptosis, 10, 11 which perpetuates cancer-associated inflammation.
Importantly, it was recently shown that circulating hematopoietic stem and progenitor cells in cancer are predominantly myeloid based. The frequency of circulating hematopoietic precursors with lymphoid potential was significantly reduced in patients with cancer, along with preferential expansion of granulocytic progenitor cells. 12 In particular, the number of granulocyte-monocyte progenitors in circulation inversely correlated with progression-free survival, and their expansion was shown to be induced by cancer-secreted cytokines, such as interleukin-6, granulocyte-macrophage colony-stimulating factor, and granulocyte colony-stimulating factor. 12 In light of the above, it is useful to seek a readily available clinical indicator of the myeloid-lymphoid status of the patients' hematopoietic system, and take advantage of that to predict prognosis. This makes peripheral blood neutrophil and lymphocyte counts attractive prognostic entities to be utilized as a gauge of the myeloid-lymphoid stoichiometry. Recent work has indeed shown a negative prognostic value of higher neutrophil-to-lymphocyte ratios (NLRs) in multiple sites of head and neck cancer. [13] [14] [15] [16] [17] [18] However, these studies had a limited sample size, were noncomprehensive in the anatomic sites studied, and/or evaluated the NLR without analyzing its individual components. In this study, we investigate the prognostic significance of neutrophils and lymphocytes independently, as well as the NLR in a large cohort of patients with oral, pharyngeal, and laryngeal cancers.
PATIENTS AND METHODS

Patient inclusion and exclusion criteria
The Cancer Registry at Hollings Cancer Center, Medical University of South Carolina (MUSC) was used to identify all cases of HNSCC (squamous cell cancers of the oral cavity, pharynx, and larynx). The study population was comprised of histologically confirmed cases diagnosed between January 1, 2000, and June 30, 2012. After excluding patients diagnosed with a second primary cancer between January 1, 1993 (the earliest date recorded) and June 30, 2013 , there were 1376 patients available for the study. Patients without recorded neutrophil or lymphocyte counts (n 5 832) or abnormally high neutrophil count suggestive of laboratory error (n 5 1) were also excluded, resulting in a total of 543 patients available for analysis. The follow-up period ranged between 2 weeks and 156 months, with a median of 64.4 months.
Data collection
The MUSC Institutional Review Board approved all study activities. For each case, we abstracted data on demographic characteristics, clinical and pathological variables at diagnosis, treatments received, and outcome using 2 different data sources: the Hollings Cancer Center cancer registry and the MUSC Clinical Data Warehouse. The registry is part of a state mandated data system that collects cancer incidence on all cases in South Carolina. The Clinical Data Warehouse is a single, secure, and integrated database extracted from the MUSC OACIS Clinical Data Repository, which includes patient demographics, International Classification of Disease-coded diagnoses, International Classification of Disease-coded procedures, medications, and laboratory test results. These databases were subsequently linked, in a blinded fashion, through an honest broker at the Clinical Data Warehouse, and entered into a secured study database.
Independent variables obtained from the Clinical Data Warehouse included pretreatment hematologic parameters (white blood cell count, neutrophil percent, absolute neutrophil count, lymphocyte percent, absolute lymphocyte count, and hemoglobin level). Variables obtained from the registry included sociodemographic characteristics (age at diagnosis, sex, and race), lifestyle factors including smoking status (never, former, and current) and alcohol use (never, former, and current), tumor grade (welldifferentiated, moderately differentiated, or poorly differentiated/undifferentiated), location of the primary tumor (oral cavity, pharynx, or larynx), TNM stage (I, II, III, or IV), all first-line therapies (chemotherapy, surgery, radiation, and/or other), and the p16 (HPV) status. The p16 status, assayed by immunohistochemistry, was used as a surrogate marker for HPV.
Data analysis
The main study outcome was overall survival. Survival time was calculated as the time from diagnosis with HNSCC to death from any cause through July 19, 2013. Subjects alive as of this date were censored at the end of follow-up. Kaplan-Meier methods were used to generate median survival time and corresponding 95% confidence intervals (CIs) for tertiles of each of the hematologic parameters (including NLR). Kaplan-Meier curves were plotted to graphically assess the relationship between hematologic parameters (described above) and survival. The log-rank test was used to assess statistical significance.
We evaluated the association between each of the hematologic parameters and survival by fitting univariate Cox proportional hazards regression models. We also studied a variable shown to be prognostic of survival in other cancer types: the NLR, which is the ratio of the absolute neutrophil count divided by the absolute lymphocyte count. To control for potential confounding variables, we performed univariate Cox proportional hazards for all other variables in Table 1 (i.e., age, sex, race, smoking status, alcohol use, treatment, tumor grade, tumor site, and clinical stage). Multivariable Cox proportional hazards models were then fit for the NLR variable (continuous) and all other variables that were found to have a p value of < .20 in the univariate analysis. Variables were retained in the final Cox proportional hazards model if they were significant at p < .05.
RESULTS
Neutrophil and lymphocyte absolute counts are inversely correlated
It is unknown whether a correlation exists between the neutrophil and lymphocyte counts in head and neck cancer. Both being products of leukopoiesis, it is reasonable to think that both lineages reflect the hematopoietic status of the white blood cell progenitors in the bone marrow, thus, conferring a positive correlation. On the other hand, it is likely that the hematopoietic system assumes a myeloid or lymphoid skewed phenotype, leading to preferentially higher lymphoid or myeloid cells, one at the expense of the other. Plotting the absolute lymphocyte and neutrophil counts demonstrates that higher absolute neutrophil numbers correlate with lower lymphocyte counts (r 5 20.11; p 5 .009; Figure 1 ).
Neutrophils correlate with shorter overall survival in head and neck squamous cell carcinoma
To determine the relationship between neutrophils and survival, each of the neutrophil percent and absolute neutrophil count was analyzed as a continuous variable. In our patient population, an increase of 10 3 neutrophils/lL resulted in 7% increase in the death hazard (Table 2 ). In turn, each increase of 1% in the neutrophil percentage conferred an increase of 1% in the hazard ratio (HR; 95% CI 5 0% to 2%; p 5 .01]. Upon categorizing the neutrophil numbers into tertiles, patients in the highest tertile were at a significantly higher risk than those in the lowest and middle tertiles (Table 2, Figure 2) . A similar pattern was observed in the multivariate analysis (Table 2) .
Lymphocytes positively correlate with overall survival
Lymphocytes were associated with longer overall survival; the risk of death decreased by 19% for every increase of 10 3 lymphocyte/lL (Table 2) . Similarly, 1% FIGURE 1. Absolute neutrophil counts inversely correlate with absolute lymphocyte counts. Absolute counts of neutrophils and lymphocytes in the peripheral venous blood of 543 patients with head and neck squamous cell carcinoma were plotted and correlation was assessed using linear regression analysis (p 5 .009). correlation coefficient (CC). Figure 3 ). Results were similar in the multivariate analysis model (Table 2 ).
Higher neutrophil-to-lymphocyte ratio is a poor prognostic marker in head and neck squamous cell carcinoma
Given the strong and opposing prognostic values observed for neutrophils and lymphocytes, it stands to reason that a higher NLR would be associated with shorter overall survival. For each 1 unit increase in the NLR, the risk of death increased by 4% (Table 2) . Patients with an NLR in the highest tertile had a significantly higher risk than those in the middle and lowest tertiles (Table 2, Figure 4) . Similar results were observed after multivariate analysis (Table 2) .
Neutrophil-to-lymphocyte ratio is lower in p16-positive tumors than p16-negative ones and confers prognostic significance in both tumor types Analysis of smoking status and alcohol consumption so far demonstrated no correlation between NLR and any of those parameters (Table 1 ; no statistical significance and a negligible magnitude of correlation). Next, we decided to investigate the correlation between HPV (p16) status Figure 5A ).
Given the strong prognostic value of NLR in the whole HNSCC population, it was further evaluated in both p16-positive and p16-negative patients. Using the continuous model, we found that within p16-negative patients, an increase of the NLR by 1 unit resulted in 7% increase in the risk of death (p 5 0.01; 95% CI 5 1.7% to 12.9%). The p16-positive patients showed a similar trend without reaching statistical significance, likely because of the small sample size; the risk of death increased by 54.9% for every 1 unit increase in NLR (p 5 .2; 95% CI 5 222% to 304%). Log-rank test within HPV (p16)-positive patients shows that those in the highest tertile have twice the risk compared to the lower two tertiles (p 5 .083; Figure 5B ). The results in the HPV-positive group did not reach statistical significance, however, likely because of the small sample size.
DISCUSSION
In this study, we report findings of the largest study to date analyzing the relationship of hematologic markers with survival outcomes in head and neck cancer. The size of the presented study also is unique in its ability to examine the relationship of hematologic markers to outcomes in several disease sites for a complex cancer in which tumor location is uniquely important. Our study establishes absolute levels of neutrophils and lymphocytes measured in circulation as independent prognostic variables in cancers of the oral cavity, pharynx, and larynx. Furthermore, we observed that the numbers of neutrophils and lymphocytes were inversely correlated and that NLR was an indicator of poor prognosis. Based on these findings, it is conceivable that the white blood cell differential in HNSCC is preferentially skewed toward either a myeloid or a lymphoid lineage, with the lymphoid preponderance being associated with better disease outcomes. We also observed a slight, but statistically significant, increase in the mean age in the upper 2 tertiles of NLR, which is in agreement with previous large scale reports. 19 Interestingly, more oral cancer cases were observed in the second and third tertiles; whether this is contributed by different flora, concomitant periodontal disease, smoking, or other factors remains to be elucidated. Nevertheless, multivariate analysis demonstrated that controlling for both factors (among others) did not affect the prognostic value of NLR.
It is noteworthy that the neutrophil and/or lymphocyte counts could be influenced by comorbid diseases in patients with cancer, such as chronic inflammatory and autoimmune diseases, along with the intake of medications associated with these conditions, such as glucocorticosteroids. In our patient population, 88 of 543 patients (16.2%) were on steroids. Steroid intake was not associated with lymphocyte counts (any vs no steroid use: 1.67 vs 1.70 3 10 3 /lL; p 5 .74), but consistent with previous reports, 20 steroid intake was significantly associated with higher neutrophil counts (any vs no steroid use: 6.82 vs 5.49 3 10 3 /lL; p 5 .0005) and higher NLR (any versus no steroid use: 5.88 vs 4.33; p 5 .008). Univariate analysis showed that the association between higher NLR and worse overall Inflammation contributes to cancer initiation and progression. For example, chronic infections are established etiological factors for a number of human cancers: Hepatitis B and C viruses in hepatoma, H. pylori in gastric cancer, and HPV in oral and cervical cancers. 21 Similarly, chronic inflammation in inflammatory bowel disease and chronic hepatitis increases the risk for colorectal and hepatocellular carcinomas, respectively. The inflammatory microenvironment induces genotoxic stress via multiple mechanisms, including reactive oxygen species and induction of activation-induced cytidine deaminase. 22 Leukocytes also propagate transformed cells by releasing cytokines, which turn on protumorigenic signals, such as the Wnt and nuclear factor-kappa B pathways. 23, 24 Relevant to HNSCC is the role of inflammation in tobaccoinduced carcinogenesis, in which tobacco induces chronic inflammation by activating the nuclear factor-kappa B and mitogen-activated protein kinase pathways, thus contributing to its ability to induce lung cancer in mice. 25 All of that highlights the cross-talk between cancer and the inflammatory microenvironment and its implications on tumor behavior. That being said, it is important to point out that the roles of different cellular subsets in dictating cancer behavior have been extensively evaluated. For example, tumor-associated macrophages promote tumor progression in preclinical models. [26] [27] [28] Similarly, regulatory CD41 T cells contribute to the progression and metastasis in a lymphoma preclinical model, 29 and predict worse outcomes in ovarian, breast, and liver cancers. [30] [31] [32] On the other hand, tumor-reactive cytotoxic T cells and subsets of helper T lymphocytes are being investigated for the clearance of established tumors in mice and humans. [33] [34] [35] [36] Previous studies have also investigated the significance of NLR in HNSCC, in which higher NLR predicted shorter disease-specific and overall survivals. 16, 17 However, these studies were limited in their sample sizes or their anatomic sites, and the results of neutrophils and lymphocytes as independent markers were either not studied or did not reach statistical significance. In this study, we included all 3 sites of HNSCC (oral, pharyngeal, and laryngeal) with a considerably larger sample size. In addition, each of neutrophils and lymphocytes were independently investigated and their predictability of survival was statistically significant. Importantly, the interaction between NLR and HPV status is an important finding in this study, although the small number of patients with known HPV status limited the robustness of our analysis. It is also important to determine whether the predictability of the NLR is affected by the HPV status of the tumor. Our analysis demonstrated a bigger magnitude of correlation between NLR and survival within the HPVpositive group than that seen in the HPV-negative group.
However, given the relatively small sample sizes, it is warranted that this aspect is further investigated in future studies. In conclusion, this analysis demonstrates the clinical significance of the 2 major circulating white blood cell types, neutrophils and lymphocytes, their prognostic usefulness in the 3 subsets of HNSCC, and the correlation of NLR with HPV status. Further retrospective and prospective studies on the efficacy of treatment when stratified by NLR category are warranted in order to obtain more refined risk stratification for the potential determination of therapy in cancers of the head and neck.
